|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
Stanford University National Institutes of Health (NIH) |
| Information provided by: | Stanford University |
| ClinicalTrials.gov Identifier: | NCT00568490 |
Purpose
To correlate tumor oxygenation as measured by the Eppendorf electrode with the serum level of secreted proteins known to be induced by tumor hypoxia.
| Condition | Intervention |
|
Head and Neck Cancer Lip Neoplasms Lip Cancer Lung Cancer |
Procedure: Eppendorf electrode measurements Procedure: Tumor biopsy Procedure: flabatomy |
| MedlinePlus related topics: | Cancer Head and Neck Cancer Lung Cancer |
| Study Type: | Observational |
| Study Design: | Prospective |
| Official Title: | Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers |
| Estimated Enrollment: | 600 |
| Study Start Date: | September 1998 |
The endpoints of the study are
Eligibility
| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:Newly diagnosed patients with head and neck cancer who has tumor accessible to tumor oxygenation measurement with a microelectrode.
Contacts and Locations| United States, California | |||||
| Stanford University School of Medicine | Recruiting | ||||
| Stanford, California, United States, 94305 | |||||
| Contact: Rachel Freiberg 650-725-4777 rachelf@stanford.edu | |||||
| Contact: Cancer Clinical Trials Office (650) 498-7061 | |||||
| Principal Investigator: Quynh-Thu Le | |||||
| Sub-Investigator: Amato Giaccia | |||||
| Sub-Investigator: Richard L Goode | |||||
| Sub-Investigator: Harlan Pinto | |||||
| Sub-Investigator: Dr. Billy W. Loo Jr. M.D. Ph.D. | |||||
| Stanford University |
| National Institutes of Health (NIH) |
| Principal Investigator: | Quynh-Thu Le | Stanford University |
More Information
| Study ID Numbers: | SU-11052007-801, 15310; CA67166, 73995, ENT0016, NCT00185822 |
| First Received: | December 4, 2007 |
| Last Updated: | June 10, 2008 |
| ClinicalTrials.gov Identifier: | NCT00568490 |
| Health Authority: | United States: Food and Drug Administration; USA:Institutional Review Board |
|
|
|